CERSCerus Corporation
2.810USD-1.40%Mkt Cap: 566.28M $P/E:

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a propriet…

Key Statistics

Company
Market Cap566.28M $
Enterprise Value583.48M $
Revenue (TTM)221.55M $
Gross Profit112.29M $
Net Income (TTM)-15.63M $
Revenue/Share1.138 USD
Last Price2.810 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees261
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-558.00
PEG
EV/EBITDA8840.61
EV/Revenue2.63
P/S2.54
P/B8.02
EPS (TTM)-0.03
EPS (Forward)-0.01
52W Range
1.15072% of range3.470
52W High3.470 USD
52W Low1.150 USD
Profitability
Gross Margin54.47%
Oper. Margin-3.23%
EBITDA Margin0.03%
Profit Margin-7.58%
ROE-24.33%
ROA-7.04%
Growth
Revenue Growth9.50%
Earnings Growth
Cash Flow & Leverage
Operating CF4.84M $
CapEx (TTM)3.73M $
FCF Margin0.40%
FCF Yield0.15%
Net Debt20.54M $
Net Debt/EBITDA311.14
Balance Sheet
Debt/Equity1.51
Current Ratio1.83
Quick Ratio1.02
Book Value/Sh0.3480 USD
Cash/Share0.2790 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.667 USD
Upside (mean)+66.1%
Target Range4.000 USD5.000 USD
$4.000+66.1% to mean$5.000
# Analysts3
Ownership
Shares Out.201.52M
Float195.32M
Insiders3.61%
Institutions73.33%
Short Interest
Short Ratio5.8d
Short % Float7.64%
Short % Out.7.42%
Shares Short14.96M
Short (prev mo.)12.74M
Technical
SMA 502.810 (-0.0%)
SMA 2002.307 (+21.8%)
Beta1.77
S&P 52W Chg18.16%
Avg Vol (30d)2.66M
Avg Vol (10d)2.75M
Technical Indicators
RSI (14)52.6
MACD-0.0016
MACD Signal-0.0530
MACD Hist.+0.0514
BB Upper3.290 USD
BB Middle2.661 USD
BB Lower2.033 USD
BB Width47.22%
ATR (14)0.1852 USD
Vol Ratio (20d)0.80x